Table 2.
Characteristics of the patients in the survival group and the death group
| Survival | Death | P value | |
|---|---|---|---|
| No. of participants (n, %) | 414 (100.0) | 186 (100.0) | ― |
| Male (n, %) | 302 (72.9) | 130 (69.9) | 0.441 |
| Age (years, mean ± S.D.) | 59.7 ± 5.8 | 67.3 ± 5.5 | 0.003 |
| Han (n, %) | 396 (95.7) | 178 (95.7) | 0.979 |
| BMI (kg/m2, mean ± S.D.) | 24.0 ± 1.2 | 26.9 ± 1.2 | 0.000 |
| Hypertension (n, %) | 201 (48.6) | 129 (69.4) | 0.000 |
| Diabetes (n, %) | 144 (34.8) | 82 (44.1) | 0.030 |
| Hyperlipidaemia (n, %) | 247 (59.7) | 131 (70.4) | 0.012 |
| CVD (n, %) | 73 (17.6) | 58 (31.2) | 0.000 |
| Drinking (n, %) | 62 (15.0) | 48 (25.8) | 0.002 |
| Aspirin (n, %) | 343 (82.9) | 165 (88.7) | 0.065 |
| Beta‐blocker (n, %) | 376 (90.8) | 133 (71.5) | 0.000 |
| ACEI/ARB (n, %) | 327 (79.0) | 119 (64.0) | 0.000 |
| Statins (n, %) | 352 (85.0) | 147 (79.0) | 0.070 |
| Prior PCI (n, %) | 34 (8.2) | 47 (25.3) | 0.000 |
| Prior CABG (n, %) | 21 (5.1) | 35 (18.8) | 0.000 |
| Current smoking (n, %) | 218 (52.7) | 117 (62.9) | 0.019 |
| Former smoking (n, %) | 64 (15.5) | 42 (22.6) | 0.034 |
| Non‐smoking (n, %) | 132 (31.9) | 27 (14.5) | 0.000 |
BMI: Body mass index; CVD: cerebrovascular disease; ACEI/ARB: Angiotensin‐converting enzyme inhibitor/Angiotensin receptor blocker; PCI: Percutaneous coronary intervention; CABG: Coronary artery bypass grafting.